LoQus23 Therapeutics nominates first-in-class oral drug candidate for Huntington’s disease
Earendil Labs to collaborate with Sanofi on bispecific antibodies for autoimmune diseases
Insilico Medicine announces $888m collaboration with Servier
Small chip predicts drug side effects and acute kidney injury